| http://www.w3.org/ns/prov#value | - Adverse Reactions Associated with Subcutaneous Use AVONEX?? has also been evaluated in 290 patients with diseases other than multiple sclerosis, primarily chronic viral hepatitis B and C, in which the doses studied ranged from 15 mcg to 75 mcg, given SC, 3 times a week, for up to 6 months.
|
